NFKB1 and allergic asthma: In the progression of allergic asthma, elevated phosphorylated (p)-NF-κB expression induces the releases of inflammatory mediators including cytokines, cyclooxygenase 2 (COX2) and matrix metalloproteinases, which eventually accelerate airway inflammation.